Within the different molecular subtypes of BCa, triple-negative breast cancer (TNBC) refers to tumors that lack expression of estrogen and progesterone receptors, as well as overexpression and/or amplification of the human epidermal growth factor receptor-2 (HER2). Here, ERBB2 is linked to triple-negative breast carcinoma.